Vyome Holdings Inc (HIND) USD0.0001

Sell:$2.67Buy:$2.90Price increased$0.44 (19.13%)

Prices delayed by at least 15 minutes
Sell:$2.67
Buy:$2.90
Change:Price increased$0.44 (19.13%)
Deal now
Prices delayed by at least 15 minutes
Sell:$2.67
Buy:$2.90
Change:Price increased$0.44 (19.13%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Vyome Holdings, Inc. is a clinical-stage healthcare holding company. The Company is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.

Key people

Krishna Gupta
Chairman of the Board
Venkateswarlu Nelabhotla
Chief Executive Officer, Director
Robert Dickey
Interim Chief Financial Officer
Mohanjit Jolly
Director
Stash Pomichter
Director
Shiladitya Sengupta
Director
John Tincoff
Director
Lori Courtney Mcdougal
Independent Director
Click to see more

Key facts

  • Shares in issue
    5.64m
  • EPIC
    HIND
  • ISIN
    US92943X1046
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $14.51m
  • Employees
    17
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.